Plunkett Research Online: Tenax Therapeutics Inc

TENAX THERAPEUTICS INC (TENX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has rel.....



Tenax Therapeutics Inc
Ticker: TENX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 919 855-2100
Fax: 919 855-2133
Address: 101 Glen Lennox Drive
Suite 300
Chapel Hill, NC 27517 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs)
Contacts Description
Christopher GiordanoCEO/Director/President
Eliot LurierCFO/Chief Accounting Officer
See More
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has rel.....See More See More

Auditor: CHERRY BEKAERT LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: